source
- China clamps down on investigator-initiated clinical trials, tightening oversightChina has announced tighter oversight of investigator-initiated trials (ITTs), requiring these studies to obtain approval from the National Medical Products Administration before they can begin. Th…
- FDA issues warning letters to Indian OTC drugmaker over falsified logbooks and cites GMP lapses at two other firmsThe FDA sent warning letters to an over‑the‑counter drug manufacturer in India after discovering the company had submitted falsified production logbooks. The agency also cited two additional OTC m…